May 2010 Briefing - Otolaryngology
Here are what the editors at HealthDay consider to be the most important developments in Otolaryngology for May 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Botox Injections Resolve Chronic Cough
THURSDAY, May 20 (HealthDay News) -- Injection with botulinum toxin type A (BtxA) can resolve chronic cough caused by laryngeal hypertonicity and neuroplastic changes, according to research published in the May issue of the Archives of Otolaryngology -- Head & Neck Surgery.
Optimism Not Linked to Plastic Surgery Satisfaction
WEDNESDAY, May 19 (HealthDay News) -- Baseline pessimism and optimism are not associated with patient satisfaction with facial plastic surgery, and those treated for depression show greater satisfaction than patients not treated for depression, according to research published in the May/June issue of the Archives of Facial Plastic Surgery.
Age Affects Benefits of Cochlear Implants
TUESDAY, May 18 (HealthDay News) -- Elderly patients can benefit significantly from cochlear implants, though not as much as younger patients on some measures, according to a study in the May issue of Archives of Otolaryngology -- Head & Neck Surgery. According to another study in the same journal, the substantial increase in endoscopic surgery for chronic sinus problems in the Medicare population is of uncertain value.
Prompt Thyroid Cancer Treatment Doesn't Improve Survival Odds
MONDAY, May 17 (HealthDay News) -- Patients who are definitively treated within a year of diagnosis for papillary thyroid cancer that is limited to the thyroid gland have survival rates that are comparable to those who do not receive definitive treatment, according to a study reported in the May issue of the Archives of Otolaryngology -- Head & Neck Surgery.
New FDA Program Targets Misleading Drug Advertising
WEDNESDAY, May 12 (HealthDay News) -- The U.S. Food and Drug Administration has announced the launch of a new program to educate health care providers regarding their role in making certain that advertisements and promotions for prescription drugs are truthful and not misleading.